Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities

Compound 3b, 4-triazole-modified zanamivir analogue, shows anti-AIV (H5N1) activity with EC50 of 6.4 μM, which is very close to that of zanamivir (EC50 = 2.8 μM).